Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus

Journal of Virology

Volumn 71, Issue 3, 1997, Pages 2202-2210

  Lane, Thomas E ^a   Paoletti, Alyssa D ^a   Buchmeier, Michael J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; IMMUNOMODULATION; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; NUDE MOUSE; OLFACTORY BULB; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0031046897     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.3.2202-2210.1997     Document Type: Article

References (51)

1. Akarid, K., M. Sinet, B. Desforges, and M. Gougerot-Pocidalo. 1995. Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J. Virol. 69:7001-7005.
2. Baier, M., A. Werner, N. Banner, K. Metzner, and R. Kurth. 1995. HIV suppression by interleukin-16. Nature 378:563.
3. Bi, Z., M. Barna, T. Komatsu, and C. Reiss, 1995. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J. Virol. 69:6466-6472.
4. Bi, Z., and C. Reiss. 1995. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:2208-2213.
5. Bredt, D., and S. Snyder. 1992. Nitric oxide, a novel neuronal messenger. Neuron 8:3-11.
6. Buchmeier, M., H. Lewicki, P. Talbot, and R. Knobler. 1984. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 132:261-270.
7. Campbell, I., A. Samimi, and C.-S. Chiang. 1994. Expression of the inducible nitric oxide synthase: correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. J. Immunol. 153:3622-3629.
8. + T cells. Science 270:1811-1815.
9. Corbett, J. A., R. G. Tilton, K. Chang, K. S. Hasan, Y. Ido, J. L. Wang, M. A. Sweetland, J. R. Lancaster, Jr., J. R. Williamson, and M. L. McDaniel. 1992. Aminoguanidine inhibits nitric oxide formation and prevents diabetic vascular dysfunction. Diabetes 41:552-556.
10. Croen, K. 1993. Evidence for an antiviral effect of nitric oxide. J. Clin. Invest. 91:2446-2452.
11. Cross, A. H., T. Misko, R. Lin, W. Hickey, J. Trotter, and R. Tilton. 1994. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:2684-2690.
12. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1742.
13. Dalziel, R. G., P. W. Lampert, P. J. Talbot, and M. J. Buchmeier. 1986. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 59:463-471.
14. Feduchi, E., M. A. Alonso, and L. Carrasco. 1989. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63:1354-1359.
15. Finke, D., U. G. Brinckmann, V. terMeulen, and U. G. Liebert. 1995. Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J. Virol. 69:5469-5474.
16. Gallagher, T. M., C. Escarmis, and M. J. Buchmeier. 1991. Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J. Virol. 65:1916-1928.
17. Harris, N., M. L. Buller, and G. Karupiah. 1995. Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69:910-915.
18. Hirano, N., N. Goto, S. Makino, and K. Fujiwara. 1978. Utility of mouse cell line DBT for propagation and assay of mouse hepatitis virus. Jpn. J. Exp. Med. 48:71-75.
19. Hooper, D. C., S. T. Ohnishi, R. Kean, Y. Numagami, B. Dietzschold, and H. Koprowski. 1995. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA 92:5312-5316.
20. Ignarro, L., H. Lippton, J. Edwards, W. Baricos, A. Hyman, P. Kudowitz, and C. Cruetter. 1981. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside, and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218:739-749.
21. Karupiah, G., Q. Xie, R. Buller, C. Nathan, C. Duarte, and J. MacMicking. 1993. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261:1445-1446.
22. Koprowski, H., Y. Zheng, E. Heber-Katz, N. Fraser, L. Rorke, F. Fangfu, C. Hanlon, and B. Dietzschold. 1993. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA 90:3024-3027.
23. Kreil, T. R., and M. M. Eibl. 1996. Nitric oxide and viral infection: no antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. Virology 219:304-306.
24. Lane, T. E., and M. J. Buchmeier. Unpublished data.
25. Levine, B., J. Hardwick, B. Trapp, T. Crawford, R. Bollinger, and D. Griffin. 1991. Antibody-mediated clearance of alphavirus infection from neurons. Science 254:856-860.
26. Lin, R. F., T.-S. Lin, R. G. Tilton, and A. H. Cross. 1993. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178:643-648.
27. Lowenstein, C. J., S. L. Hill, A. Lafond-Walker, J. Wu, G. Allen, M. Landsvere, N. R. Rose, and A. Herskowitz. 1996. Nitric oxide inhibits viral replication in murine myocarditis. J. Clin. Invest. 97:1837-1843.
28. Lowenstein, C. J., C. S. Glatt, D. S. Bredt, and S. H. Snyder. 1992. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA 89:6711-6715.
29. Marletta, M. A., P. S. Yoon, R. Iyengar, C. D. Leaf, and J. S. Wishnok. 1988. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27:8706-8711.
30. Melkova, Z., and M. Esteban. 1995. Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase. J. Immunol. 155: 5711-5718.
31. Merrill, J. E., L. J. Ignarro, M. P. Sherman, J. Melinek, and T. E. Lane. 1993. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:2132-2141.
32. Misko, T. P., W. M. Moore, T. P. Kasten, G. A. Nickols, J. A. Corbett, R. G. Tilton, M. L. McDaniel, J. R. Williamson, and M. G. Currie. 1993. Selective inhibition of the inducible nitric oxide synthase enzyme by aminoguanidine. Eur. J. Pharmacol. 233:119-122.
33. Moncada, S., R. Palmer, and E. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
34. Nathan, C., and J. Hibbs. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70.
35. Nathan, C., and Q. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918.
36. Oldstone, M. B. A., P. Blount, P. Southern, and P. Lampert. 1986. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature 321:239-243.
37. Pearce, B. D., M. V. Hobbs, T. S. McGraw, and M. J. Buchmeier. 1994: Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J. Virol. 68:5483-5495.
38. Ramsay, A., J. Ruby, and I. Ramshaw. 1993. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 14:155-157.
39. Rodriguez, M., K. Pavelko, and R. Coffman. 1995. Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol. 69: 7286-7290.
40. Rolph, M. S., I. A. Ramshaw, K. A. Rockett, J. Ruby, and W. B. Cowden, 1996. Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance. Virology 217:470-477.
41. Ryder, E., E. Snyder, and C. Lepko. 1990. Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. J. Neurobiol. 21:356-375.
42. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
43. Simmons, M. L., and S. Murphy. 1992. Induction of nitric oxide synthase in glial cells. J. Neurochem. 59:897-905.
44. Smith, A., S. Barthold, M. de Souza, and K. Bottomly. 1991. The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM. Arch. Virol. 121:89-100.
45. Sun, N., D. Grzybicki, R. F. Castro, S. Murphy, and S. Perlman. 1995. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213:482-493.
46. Sussman, M. A., R. A. Shubin, S. Kyuwa, and S. A. Stohlman. 1989. T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J. Virol. 63:3051-3056.
47. Tishon, A., H. Lewicki, G. Rall, M. von Herrath, and M. B. A. Oldstone. 1995. An essential role for type-1 interferon-γ in terminating persistent viral infection. Virology 212:244-250.
48. Tucker, P. C., D. E. Griffin, S. Choi, N. Bui, and S. Wesselingh. 1996. Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis. J. Virol. 70:3972-3977.
49. + T cells. J. Virol. 64:4589-4592.
50. Zheng, Y. M., M. K.-H. Schafer, E. Weihe, H. Sheng, S. Corisdeo, Z. F. Fu, H. Koprowski, and B. Dietzschold. 1993. Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase. J. Virol. 67:5786-5791.
51. Zinkernagel, R. M. 1993. Immunity to viruses, p. 1211-1250. In W. K. Paul (ed.), Fundamental immunology, 3rd ed. Raven Press, New York, N.Y.